This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Experts
Rebecca Fink
Principal Research Scientist
Contact
RebeccaFink@c178.netOverview
Rebecca Fink, MPH, is a Principal Research Scientist with 13 years of experience designing and implementing multisite epidemiologic research studies, online panel surveys, public health interventions, and evaluations for clients such as CDC, NIH, and HRSA. Her areas of expertise include infectious diseases epidemiology, maternal and child health, multisite study coordination, protocol development, survey design, data management, and data analysis. She is the Project Director for the CDC-funded National SARS-CoV-2 Seroprevalence Studies in Blood Donors project. This project built off work conducted as part of the NIH-funded REDS Epidemiology, Surveillance, and Preparedness of the Novel SARS-CoV-2 Epidemic program, for which Fink served as the Project Manager. She also serves as the Deputy Project Director for a CDC-funded Phase IV trial to examine the relative efficacy of a second-generation influenza vaccine as compared to a standard dose vaccine.
In earlier work, Fink served as Project Director for CDC-funded online panel surveys to monitor vaccination coverage and practices in pregnant women, health care personnel, and a general adult population. Fink has coauthored numerous peer-reviewed publications on SARS-CoV-2 seroprevalence and influenza vaccination coverage.
Education
- MPH, School of Public Health, Boston University, Epidemiology and Biostatistics
- BS (magna cum laude), Boston University, Health Science
-
Accuracy of COVID-19-like illness diagnoses in electronic health record data: Retrospective cohort study
7,
JMIR Formative Research
January 2023
S. Rao, C. Bozio, K. Butterfield, S. Reynolds, S.E. Reese, Sarah Ball, A. Steffens, et al.
DOILink for: Accuracy of COVID-19-like illness diagnoses in electronic health record data: Retrospective cohort study -
Use of US blood donors for national serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 antibodies: Basis for an expanded national donor serosurveillance program
74,
Clinical Infectious Diseases
January 2022
M. Stone, C. Di Germanio, D.J. Wright, H. Sulaeman, H. Dave, Rebecca Fink, E.P. Notari, et al.
DOILink for: Use of US blood donors for national serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 antibodies: Basis for an expanded national donor serosurveillance program -
How do we...form and coordinate a national serosurvey of SARS-CoV-2 within the blood collection industry?
62,
Transfusion
January 2022
Rebecca Fink, L. Fisher, H. Sulaeman, H. Dave, M.E. Levy, L. McCann, C. Di Germanio, et al.
DOILink for: How do we...form and coordinate a national serosurvey of SARS-CoV-2 within the blood collection industry?